MedTrace Logo

Use of Information Technology in the Prevention of Diabetes

NCT00819455 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 537

Last updated 2013-02-15

No results posted yet for this study

Summary

Type 2 diabetes is a major and increasing problem in India and the UK. In clinical trials it can be prevented in people at high risk by lifestyle intervention. While these trials established the proof of principle, they involved a degree of input from healthcare professionals not feasible outside the trial situation. We hypothesize that diabetes prevention can be achieved at lower cost using personalised feedback via mobile phone, based on information on healthy diet and physical activity habits. We shall develop research protocols and computerized algorithms to test this hypothesis in India for application subsequently in the UK and elsewhere.

Conditions

Interventions

BEHAVIORAL

Experimental

Active Life style modification-motivation by I.T technology

BEHAVIORAL

Control arm (usual care/standard care arm)

Life style modification only once

Sponsors & Collaborators

  • Imperial College London

    collaborator OTHER

  • India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals

    lead OTHER

Principal Investigators

  • Ambady Ramachandran, M.D, D.Sc · President, India Diabetes Research Foundation and Chairman & Managing Director, Dr.A.Ramachandran's Diabetes Hospitals

  • Desmond Geoffrey Johnston, MB Ch B, Ph.D · Professor of Clinical Endocrinology, Imperial College, London

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00819455 on ClinicalTrials.gov